Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00359736 · ClinicalTrials.gov registry record · Phase 2
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT00359736: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00359736 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00359736, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
Medicines that decrease blood pressure in the lungs may help idiopathic pulmonary fibrosis (IPF) patients function better. This study will test whether sildenafil improves the ability to exercise in patients with pulmonary fibrosis of unknown cause.
Interventions
- DRUG sildenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00359736
The ClinicalTrials.gov registry entry for NCT00359736 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sildenafil is the first listed.
NCT00359736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00359736 about?
NCT00359736 is a clinical study titled "Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis". Medicines that decrease blood pressure in the lungs may help idiopathic pulmonary fibrosis (IPF) patients function better. This study will test whether sildenafil improves the ability to exercise in patients with pulmonary fibrosis of unknown cause.
What is the current status of trial NCT00359736?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2006-07. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00359736?
The interventions under investigation include: sildenafil (DRUG).
Who is sponsoring clinical trial NCT00359736?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.